Good find bigjez, comprehensive article.
Exciting to think that the Opdivo/ Yerevoy combo in melanoma is better than either treatment as monotherapies. But more exciting to see that
Relativity-047 is outdoing that incumbant combo on the exposed results so far, both as adjuvent and monotherapies as well. Lag3 is seriously looking the goods, fingers crossed the FDA sees it to be as worthy as the results are proving for patients.
Looks to me EFTI is off and running on the back of the immenent Relativity-047 approval. Fingers are tightly crossed here.
IMO
DYOR
Good Luck to ALL Patients and LTH.
Overnight Market report, page-299
-
- There are more pages in this discussion • 2,638 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |